6 results match your criteria: "The Netherlands m.drent@maastrichtuniversity.nl.[Affiliation]"

Benefits of Physical Training in Sarcoidosis.

Lung

October 2015

ild care foundation research team, PO Box 18, 6720 AA, Bennekom, The Netherlands.

Background: Sarcoidosis patients suffer from fatigue and exercise limitation. The aim of this study was to establish whether a physical training program improves these and other outcomes important to sarcoidosis patients.

Methods: From 11/2012 to 9/2014, 201 sarcoidosis patients were referred to the ild care expertise team, Ede, the Netherlands.

View Article and Find Full Text PDF

Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis.

Eur Respir J

June 2014

Dept of Interstitial Lung Diseases, Gelderse Vallei Hospital, Ede, The Netherlands Dept of Toxicology, Maastricht University, Maastricht, The Netherlands

Responsiveness to tumour necrosis factor (TNF) inhibitors has been associated with the TNF-α G-308A polymorphism in rheumatoid arthritis. The aim of this study was to examine the association between the presence of this polymorphism and the response to TNF inhibitors in patients with refractory sarcoidosis. Patients (n=111) who started TNF-inhibitor treatment (76 infliximab, 35 adalimumab) were followed for at least 1 year.

View Article and Find Full Text PDF

Professor Om Prakash Sharma 1936-2012.

Curr Opin Pulm Med

January 2013

Department of Interstitial Lung Diseases, Hospital Gelderse Vallei, Ede, The Netherlands.

View Article and Find Full Text PDF

Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy.

Curr Med Chem

May 2013

Faculty of Health, Medicine and Life Science, University Maastricht, Faculty of Health, Medicine and Life Science, UNS 40 room 4.550, PO Box 3100 6202 NC Maastricht, The Netherlands.

Medicinal agents, beside occupational and environmental agents, remain one of the most common causes for interstitial lung diseases (ILD). A major problem with ILD is the recognition of the causative agent. In some cases more or less characteristic features of presentation are described.

View Article and Find Full Text PDF

Sarcoidosis-associated fatigue.

Eur Respir J

July 2012

Dept of Interstitial Lung Diseases, Hospital Gelderse Vallei, Ede, The Netherlands.

Sarcoidosis-associated fatigue is globally recognised as a disabling symptom. Fatigue has been reported in up to 50-70% of sarcoidosis patients, causing impaired quality of life. The aetiology of this troublesome problem remains elusive and is usually multifactorial.

View Article and Find Full Text PDF